Last Posted: Jun 27, 2024
- Comparative policy analysis of national rare disease funding policies in Australia, Singapore, South Korea, the United Kingdom and the United States: a scoping review.
Qin Xiang Ng et al. Health Econ Rev 2024 14(1) 42 - Spinal muscular atrophy genetic epidemiology and the case for premarital genomic screening in Arab populations.
Fatma Rabea et al. Commun Med (Lond) 2024 4(1) 119 - Epidemiology of Spinal Muscular Atrophy Based on the Results of a Large-Scale Pilot Project on 202,908 Newborns.
Irina Yu Efimova et al. Pediatr Neurol 2024 156147-154 - Medicaid spending and utilization of gene and RNA therapies for rare inherited conditions.
Ilina C Odouard et al. Health Aff Sch 2024 2(5) qxae051 - Results of a Pilot External Quality Assessment Scheme for Genetic Testing of Newborns with Spinal Muscular Atrophy.
Wei Wang et al. Clin Lab 2024 70(5) - Long-Term Follow-Up Cares and Check Initiative: A Program to Advance Long-Term Follow-Up in Newborns Identified with a Disease through Newborn Screening.
Mei Lietsch et al. Int J Neonatal Screen 2024 10(2) - Clinical application value of pre-pregnancy carrier screening in Chinese Han childbearing population.
Li Tan et al. Mol Genet Genomic Med 2024 12(4) e2425 - Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial.
Oliver Schwartz et al. JAMA Pediatr 2024 4 - Assessment of Barriers to Referral and Appointment Wait Times for the Evaluation of Spinal Muscular Atrophy (SMA): Findings from a Web-Based Physician Survey.
Mary A Curry et al. Neurol Ther 2024 - Detecting missed diagnoses of spinal muscular atrophy in genome, exome, and panel sequencing datasets.
Ben Weisburd et al. medRxiv 2024
More
Search Result Summary
- CDC Information (0)
- NIH Information (14)
- CDC Publications (5)
- Hot Topics Archive (44)
- COVID-19 (4)
- Human Genome Epidemiologic Studies (128)
- GWAS Studies (0)
- Genomics Precision Health (249)
- Non-Genomics Precision Health (0)
- Pathogen Advanced Molecular Detection (0)
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.